ALFA Filings
Every announcement, straight from the exchange
Every Remus Pharmaceuticals annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Remus Pharmaceuticals Limited shareholders approved the migration of equity shares from the NSE Emerge platform to the main boards of NSE and BSE.
Remus Pharmaceuticals held its 11th Annual General Meeting on September 29, 2026. Shareholders discussed financial results, dividend declaration, and director appointments.
Remus Pharmaceuticals Limited has issued a postal ballot notice seeking shareholder approval for the migration of its equity shares from the NSE Emerge platform to Main Board.